Hi everyone.
On 14/02/2023, our system had provided a few picks and the results are as below:
FANG – (Buy) – Profit
QBTS – (Buy) – In the Market
LYEL – (Buy) – In the Market
FSR – (Buy) – Price Not Done
All three major US indexes finished in the green on Monday, and passed the worst week of the year so far, as investors looked for clues on interest rate path in Fed officials’ latest comments while awaited the upcoming US inflation report due tomorrow. The Dow added almost 370 points on Monday, while the S&P 500 and Nasdaq 100 were up 1.1% and 1.4%, respectively.
Let’s review our stock picks on Tuesday.
A call for buy for FANG which resulted in profit. Our system entered the market at $146.58 and made a call to profit at $148.10, which is our trailing stop loss.
Diamondback Energy, Inc., an independent oil and natural gas company, focuses on the acquisition, development, exploration, and exploitation of unconventional and onshore oil and natural gas reserves in the Permian Basin in West Texas. It focuses on the development of the Spraberry and Wolfcamp formations of the Midland basin; and the Wolfcamp and Bone Spring formations of the Delaware basin, which are part of the Permian Basin in West Texas and New Mexico.
A call for buy for QBTS which is still in the market. Our system picked this stock as a swing trade and it is currently trading below our EP in the market. Follow this stock for all status updates.
D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Launch, a quantum computing onboarding service; Ocean a full suite of open-source programming tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community.
A call for buy for LYEL which is still in the market. Our system picked this stock as a swing trade and it is currently trading below our EP in the market. Follow this stock for all status updates.
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate for the treatment of non-small cell lung cancer and triple negative breast cancers; LYL845, that targets multiple solid tumors; and NY-ESO-1 for synovial sarcoma and other solid tumor indications.
A call for buy for FSR which did not enter the market. Our system put an order to enter the market at $6.39 but the price did not hit our EP and went upwards throughout the market.
Fisker Inc. develops, manufactures, markets, leases, or sale of electric vehicles. The company is also involved in asset-light automotive business. It operates through The White Space, The Value Segment, and The Conservative Premium segments.
Stay tuned for more of our stock picks.
Want the next pick before it's written up?
AIRESCAN's AI publishes live recommendations in the app.